Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 1]
Pharmac To Fund Two New Combination Treatments, And Widen Access To Another, For People With A Type Of Blood Cancer
Thursday, 9 April 2026, 11:35 am | PHARMAC
The decision follows consultation with people with CLL, their families, clinicians, and consumer advocacy groups. More >>
Pharmac Funds Medicine To Reduce Complications Following Allogenic Haematopoietic Stem Cell Transplant
Wednesday, 8 April 2026, 2:40 pm | PHARMAC
The medicine will be funded for use in hospitals and through community pharmacies. Around 90 people are expected to benefit in the first full year of funding. More >>
Pharmac Invites Feedback Before Possible Medicine Brand Changes
Wednesday, 8 April 2026, 11:27 am | PHARMAC
No decisions have been made about whether any medicine brands will change. Feedback from the consultation will be considered alongside clinical and technical advice before any decisions are made. More >>
Pharmac Widens Access To Two Melanoma Medicines
Tuesday, 7 April 2026, 11:37 am | PHARMAC
Clinical advice provided to Pharmac shows that these treatments can reduce the risk of melanoma coming back. More >>
Pharmac Proposal To Procure Drug-Eluting Stents Will Mean Savings For Public Hospitals
Thursday, 26 March 2026, 2:05 pm | PHARMAC
The proposed deal would award Principal Supply Status for permanent coronary drug-eluting stents for public hospitals to Medtronic New Zealand. Hospitals would be able to invest the proposed savings into new and emerging technologies. More >>
Pharmac Seeks Feedback To Make Access To Medicines Clearer & Simpler For People With Exceptional Clinical Circumstances
Tuesday, 17 March 2026, 11:21 am | PHARMAC
The Framework is used when a person’s clinical situation is unusual or complex and existing funded medicines or standard funding rules are not suitable. More >>
Pharmac Widening Access To A Treatment For People With A Rare Blood Cancer
Thursday, 12 March 2026, 1:52 pm | PHARMAC
This change comes after Pharmac consulted on a proposal for brentuximab vedotin to be used as a first-line treatment option in people newly diagnosed with sALCL. More >>
Funding Change Will Ensure More Consistent Emergency Care For New Zealanders
Thursday, 12 March 2026, 12:56 pm | PHARMAC
Pharmac is proposing changes to the Pharmaceutical Schedule to support the Government’s decision to shift responsibility for funding ambulance medicines from Health New Zealand and ACC to Pharmac. More >>
New Proposal Aims To Reduce Complications Following A Stem Cell Transplant
Thursday, 5 March 2026, 11:27 am | PHARMAC
Pharmac is consulting on a proposal to fund letermovir, an antiviral medicine that helps prevent cytomegalovirus (CMV) infection. More >>
Pharmac Proposes To Widen Access To Two Medicines For People With Melanoma
Tuesday, 24 February 2026, 1:51 pm | PHARMAC
Pharmac’s clinical advisors have said that using these treatments together, before surgery, and then adjusting treatment after surgery based on how well the cancer has responded, can lower the chance of melanoma coming back. More >>
Pharmac Proposes Funding New Treatments That Could Transform Early Care For People With Chronic Lymphocytic Leukaemia
Wednesday, 18 February 2026, 12:59 pm | PHARMAC
Pharmac is consulting on a change that would fund two new treatment combinations - venetoclax with ibrutinib, and venetoclax with obinutuzumab - for people with CLL. More >>
New Iron Treatment Funded For People Who Have Experienced Serious Reactions
Tuesday, 17 February 2026, 3:12 pm | PHARMAC
Approximately 100 people are expected to benefit from this treatment each year. More >>
Pharmac Seeking Feedback On Plans To Modernise The Pharmaceutical Schedule
Thursday, 12 February 2026, 2:23 pm | PHARMAC
The redevelopment project aims to make the Schedule clearer, easier to navigate, and simpler to keep up to date. More >>
Improving Access To Medicines In Rural Communities
Monday, 9 February 2026, 8:39 pm | PHARMAC
Pharmac is also funding ketamine for uncontrollable pain in people receiving palliative care in their communities. More >>
Pharmac Proposes Wider Access To A Treatment For People With A Rare Blood Cancer
Wednesday, 4 February 2026, 11:24 am | PHARMAC
Pharmac is consulting on a change that would allow brentuximab vedotin to be used as a first-line treatment option for people newly diagnosed with sALCL. If approved, the treatment would be funded from 1 April 2026. More >>
Pharmac Proposes To Fund LifeChanging Treatments For People With Cystic Fibrosis
Thursday, 22 January 2026, 1:14 pm | PHARMAC
Cystic fibrosis is a longterm condition that affects around 500 New Zealanders, including children. There is no cure, and people with the condition often have shorter lives. More >>
New Iron Treatment Proposed For People Who Have Experienced Low Phosphate Levels
Tuesday, 20 January 2026, 11:50 am | PHARMAC
Pharmac is keen to hear from patients, health professionals, pharmacists, and anyone interested in this change. More >>
Pharmac Funds Treatment For Rare Disorders
Monday, 12 January 2026, 11:54 am | PHARMAC
Clinicians have supported this decision, saying it will make access to treatment simpler for their patients. More >>
Pharmac Will Not Proceed With Proposed Changes To How It Manages The Options For Investment List
Wednesday, 17 December 2025, 11:13 am | PHARMAC
“People told us that while they understood our aim was to improve transparency, they did not want us to remove funding applications from the OFI,” says Pharmac’s Director Pharmaceuticals, Adrienne Martin. More >>
Pharmac Proposes Improved Access To Emergency Medicines In Rural And Remote Communities
Monday, 1 December 2025, 2:06 pm | PHARMAC
Pharmac is working with Health NZ, ACC, ambulance services, rural GPs, midwives, and palliative care providers to understand how the proposed changes would work in practice. More >>
